Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and …

E Temfack, JJB Rim, R Spijker, A Loyse… - Clinical Infectious …, 2021 - academic.oup.com
Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.
We searched MEDLINE and Embase for studies where CrAg detection in …

High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients

RM Wake, E Britz, C Sriruttan, I Rukasha… - Clinical Infectious …, 2018 - academic.oup.com
Background High mortality rates among asymptomatic cryptococcal antigen (CrAg)–positive
patients identified through CrAg screening, despite preemptive fluconazole treatment, may …

Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative cerebral spinal fluid analysis

K Ssebambulidde, AS Bangdiwala… - Clinical Infectious …, 2019 - academic.oup.com
Background Individuals with cryptococcal antigenemia are at high risk of developing
cryptococcal meningitis if untreated. The progression and timing from asymptomatic infection …

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

JN Jarvis, A Percival, S Bauman… - Clinical infectious …, 2011 - academic.oup.com
Background. Many deaths from cryptococcal meningitis (CM) may be preventable through
early diagnosis and treatment. An inexpensive point-of-care (POC) assay for use with urine …

Cryptococcal antigen screening in asymptomatic HIV-infected antiretroviral naïve patients in Cameroon and evaluation of the new semi-quantitative Biosynex …

E Temfack, C Kouanfack, L Mossiang, A Loyse… - Frontiers in …, 2018 - frontiersin.org
Background: Cryptococcal meningitis (CM) is a major cause of AIDS-related mortality in
Africa. Detection of serum cryptococcal antigen (CrAg) predicts development of CM in …

Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.

TY Lin, KM Yeh, JC Lin, NC Wang… - … , and infection= Wei …, 2009 - europepmc.org
Background and purpose Cryptococcus neoformans is an encapsulated pathogenic yeast
that causes a wide range of clinical manifestations. The serum cryptococcal latex …

CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis

N Ford, Z Shubber, JN Jarvis, T Chiller… - Clinical Infectious …, 2018 - academic.oup.com
Background Current guidelines recommend screening all people living with human
immunodeficiency virus (PLHIV) who have a CD4 count≤ 100 cells/µL for cryptococcal …

Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing

R Rajasingham, RM Wake, T Beyene… - Journal of clinical …, 2019 - Am Soc Microbiol
Over the past ten years, standard diagnostics for cryptococcal meningitis in HIV-infected
persons have evolved from culture to India ink to detection of cryptococcal antigen (CrAg) …

Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature

JE Kaplan, S Vallabhaneni, RM Smith… - JAIDS Journal of …, 2015 - journals.lww.com
Background: Screening individuals with AIDS for serum cryptococcal antigen (CrAg),
followed by treatment of CrAg positives with antifungals, may prevent cryptococcal …

Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive human immunodeficiency virus–infected adults …

E Temfack, JJ Bigna, HN Luma, R Spijker… - Clinical Infectious …, 2019 - academic.oup.com
Cryptococcal antigen (CrAg) screening and targeted preemptive fluconazole in antiretroviral-
naive human immunodeficiency virus–infected adults with CD4 cell counts< 100/μL seems …